Back to results
US 12,741,953 B2Granted
Phthalazinone compound, and preparation method therefor and medical use thereof
AssigneeShanghai Jeyou Pharmaceutical Co., Ltd.
InventorsHongfu Lu, Weiqiang Xing, Yongcong Lv, Baojian Qi, Jianbiao Peng, Haibing Guo
Life of this patent
Estimating the term…
Abstract
Disclosed are a phthalazinone compound, and a preparation method therefor and the medical use thereof. In particular, disclosed are a compound as represented by formula (I), and a pharmacodynamically acceptable salt, and the use of the compound as an androgen receptor (AR) for degradation.
Claims16
A compound as represented by formula (I), an optical isomer thereof, or a pharmacodynamically acceptable salt thereof,
- wherein
- R1 is selected from H, F, Cl, Br, I and C1-6 alkyl, and the C1-6 alkyl is optionally substituted with 1, 2 or 3 R;
- G is selected from H, F, Cl, Br, I and C1-6 alkyl, and the C1-6 alkyl is optionally substituted with 1, 2 or 3 R;
- ring B is selected from phenyl and 5- to 6-membered heteroaryl, and the phenyl or 5- to 6-membered heteroaryl is optionally substituted with 1, 2 or 3 R;
- ring C is C4-6 cycloalkyl;
- R2 is selected from H and C1-6 alkyl, and the C1-6 alkyl is optionally substituted with 1, 2 or 3 R;
- ring A is selected from 6- to 12-membered aryl and 5- to 12-membered heteroaryl;
- RA is selected from H, NO2, halogen, NH2, CN, C1-6 alkyl and C1-6 alkoxy, and the C1-6 alkyl or C1-6 alkoxy is optionally substituted with 1, 2 or 3 R;
- RD is selected from H, CN, halogen, C1-6 alkyl, C1-6 alkoxy, C3-6 cycloalkyl and 3- to 6-membered heterocycloalkyl, and the C1-6 alkyl, C1-6 alkoxy, C3-6 cycloalkyl or 3- to 6-membered heterocycloalkyl is optionally substituted with 1, 2 or 3 R;
- R is independently selected from H, F, Cl, Br, I, OH, NH2 and C1-6 alkyl, and the C1-6 alkyl is optionally substituted with 1, 2 or 3 R′;
- L1, L2 and L3 are independently selected from a single bond, O, S, NH, C(═O), S(═O), S(═O)2, C1-6 alkyl, —C1-6 alkyl-O—, C2-3 alkenyl, C2-3 alkynyl, C3-10 cycloalkyl, 3- to 10-membered heterocycloalkyl, phenyl and 5- to 9-membered heteroaryl, and the C1-6 alkyl, —C1-6 alkyl-O—, C2-3 alkenyl, C2-3 alkynyl, C3-10 cycloalkyl, 3- to 10-membered heterocycloalkyl, phenyl or 5- to 9-membered heteroaryl is optionally substituted with 1, 2 or 3 RL;
- RL is independently selected from H, halogen, OH, NH2, CN,
- C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkyl-C(═O)—, C1-6 alkoxy, C1-6 alkylthio and C1-6 alkylamino, and the C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkyl-C(—O)—, C1-6 alkoxy, C1-6 alkylthio or C1-6 alkylamino is optionally substituted with 1, 2 or 3 R′;
- R′ is independently selected from H, halogen, C1-6 alkyl, OH, NH2,
- CH3, CH2F, CHF2 and CF3;
- n is 0, 1, 2, 3 or 4;
- m is 0, 1, 2, 3 or 4;
- q is 1, 2, 3 or 4;
- and
- the 3- to 10-membered heterocycloalkyl, 3- to 6-membered heterocycloalkyl, 5- to 12-membered heteroaryl, 5- to 6-membered heteroaryl or 5- to 9-membered heteroaryl comprises 1, 2 or 3 heteroatoms or heteroatom groups independently selected from O, NH, S, C(═O), C(═O) O, S(═O), S(═O)2 and N.
17 more elements
Dependencies are inferred from the claim text.